An expanded sequence context model broadly explains variability in polymorphism levels across the human genome

Nature Genetics

Volumn 48, Issue 4, 2016, Pages 349-355

  Aggarwala, Varun ^a   Voight, Benjamin F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLCYTOSINE; AMINO ACID; DINUCLEOTIDE; TRINUCLEOTIDE; SPACER DNA;

AMINO ACID SUBSTITUTION; ARTICLE; AUTISM; COMPARATIVE STUDY; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EFFECTIVE POPULATION SIZE; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN GENOME; MENTAL DISEASE; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PURIFYING SELECTION; REPRODUCTIVE FITNESS; SINGLE NUCLEOTIDE POLYMORPHISM; SPONTANEOUS MUTATION; X CHROMOSOME; BAYES THEOREM; BIOLOGICAL MODEL; DNA SEQUENCE; GENETICS; MUTATION; REGRESSION ANALYSIS;

AUTISTIC DISORDER; BASE SEQUENCE; BAYES THEOREM; CPG ISLANDS; DNA METHYLATION; DNA, INTERGENIC; GENOME, HUMAN; HUMANS; MODELS, GENETIC; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; SEQUENCE ANALYSIS, DNA;

EID: 84958093480     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3511     Document Type: Article

References (49)

1. Hodgkinson, A., & Eyre-Walker, A. Variation in the mutation rate across mammalian genomes. Nat. Rev. Genet. 12, 756-766 (2011
2. Ehrlich, M., & Wang, R.Y. 5-methylcytosine in eukaryotic DNA. Science 212, 1350-1357 (1981
3. Rideout, W.M. III, Coetzee, G.A., Olumi, A.F., & Jones, P.A. 5-methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 249, 1288-1290 (1990
4. Arbiza L., et al. Genome-wide inference of natural selection on human transcription factor binding sites. Nat. Genet. 45, 723-729 (2013
5. Yang Y., et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N. Engl. J. Med. 369, 1502-1511 (2013
6. Hwang, D.G., & Green, P. Bayesian Markov chain Monte Carlo sequence analysis reveals varying neutral substitution patterns in mammalian evolution. Proc. Natl. Acad. Sci. USA 101, 13994-14001 (2004
7. Blake, R.D., Hess, S.T., & Nicholson-Tuell, J. The influence of nearest neighbors on the rate and pattern of spontaneous point mutations. J. Mol. Evol. 34, 189-200 (1992
8. Neale B.M., et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485, 242-245 (2012
9. Michaelson J.J., et al. Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Cell 151, 1431-1442 (2012
10. Fromer M., et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179-184 (2014
11. Lawrence M.S., et al. Mutational heterogeneity in cancer and the search for new cancer-Associated genes. Nature 499, 214-218 (2013
12. Samocha K.E., et al. A framework for the interpretation of de novo mutation in human disease. Nat. Genet. 46, 944-950 (2014
13. 1000 Genomes Project Consortium. An integrated map of genetic variation from 1 092 human genomes Nature 491 56-65 2012
14. International HapMap Consortium. A haplotype map of the human genome. Nature 437 1299-1320 (2005
15. Campbell, M.C., & Tishkoff, S.A. African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Annu. Rev. Genomics Hum. Genet. 9, 403-433 (2008
16. Schaffner, S.F. The X chromosome in population genetics. Nat. Rev. Genet. 5, 43-51 (2004
17. Nachman, M.W., & Crowell, S.L. Estimate of the mutation rate per nucleotide in humans. Genetics 156, 297-304 (2000
18. Mugal, C.F., & Ellegren, H. Substitution rate variation at human CpG sites correlates with non-CpG divergence, methylation level and GC content. Genome Biol. 12, R58 (2011
19. Okae H., et al. Genome-wide analysis of DNA methylation dynamics during early human development. PLoS Genet. 10, e1004868 (2014
20. Hovestadt V., et al. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing. Nature 510, 537-541 (2014
21. Walser, J.-C., & Furano, A.V. The mutational spectrum of non-CpG DNA varies with CpG content. Genome Res. 20, 875-882 (2010
22. Kamiya, H., et al. Mutagenicity of 5-formylcytosine, an oxidation product of 5-methylcytosine, in DNA in mammalian cells. J. Biochem. 132, 551-555 (2002
23. Deaton, A.M., & Bird, A. CpG islands and the regulation of transcription. Genes Dev. 25, 1010-1022 (2011
24. Levinson, G., & Gutman, G.A. Slipped-strand mispairing: a major mechanism for DNA sequence evolution. Mol. Biol. Evol. 4, 203-221 (1987
25. Panchin, A.Y., Mitrofanov, S.I., Alexeevski, A.V., Spirin, S.A., & Panchin, Y.V. New words in human mutagenesis. BMC Bioinformatics 12, 268 (2011
26. Lanfear, R., Welch, J.J., & Bromham, L. Watching the clock: studying variation in rates of molecular evolution between species. Trends Ecol. Evol. 25, 495-503 (2010
27. Kong A., et al. Rate of de novo mutations and the importance of fathers age to disease risk. Nature 488, 471-475 (2012
28. Bustamante C.D., et al. Natural selection on protein-coding genes in the human genome. Nature 437, 1153-1157 (2005
29. Fu, W., et al. Analysis of 6, 515 exomes reveals the recent origin of most human protein-coding variants. Nature 493, 216-220 (2013
30. Cooper, G.M., & Shendure, J. Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data. Nat. Rev. Genet. 12, 628-640 (2011
31. Stenson, P.D., et al. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum. Genet. 133, 1-9 (2014
32. Petrovski, S., Wang, Q., Heinzen, E.L., Allen, A.S., & Goldstein, D.B. Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet. 9, e1003709 (2013
33. Georgi, B., Voight, B.F., & Bućan, M. From mouse to human: evolutionary genomics analysis of human orthologs of essential genes. PLoS Genet. 9, e1003484 (2013
34. Uddin M., et al. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder. Nat. Genet. 46, 742-747 (2014
35. De Rubeis, S., et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515, 209-215 (2014
36. Epi4K Consortium & Epilepsy Phenome/Genome Project. De novo mutations in epileptic encephalopathies. Nature 501 217-221 (2013
37. Deciphering Developmental Disorders Study. Large-scale discovery of novel genetic causes of developmental disorders. Nature 519 223-228 (2015
38. Hamdan F.F., et al. De novo mutations in moderate or severe intellectual disability. PLoS Genet. 10, e1004772 (2014
39. Rauch A., et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 380, 1674-1682 (2012
40. de Ligt J., et al. Diagnostic exome sequencing in persons with severe intellectual disability. N. Engl. J. Med. 367, 1921-1929 (2012
41. Ginsburg, D., & Bowie, E.J. Molecular genetics of von Willebrand disease. Blood 79, 2507-2519 (1992
42. Iossifov I., et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 515, 216-221 (2014
43. Orosco L.A., et al. Loss of Wdfy3 in mice alters cerebral cortical neurogenesis reflecting aspects of the autism pathology. Nat. Commun. 5, 4692 (2014
44. Eyre-Walker, A., & Eyre-Walker, Y.C. How much of the variation in the mutation rate along the human genome can be explained? G3 (Bethesda) 4, 1667-1670 (2014
45. Kimura, M., & Ohta, T. On some principles governing molecular evolution. Proc. Natl. Acad. Sci. USA 71, 2848-2852 (1974
46. Ségurel, L., Wyman, M.J., & Przeworski, M. Determinants of mutation rate variation in the human germline. Annu. Rev. Genomics Hum. Genet. 15, 47-70 (2014
47. Hussin J.G., et al. Recombination affects accumulation of damaging and disease-Associated mutations in human populations. Nat. Genet. 47, 400-404 (2015
48. Koren A., et al. Genetic variation in human DNA replication timing. Cell 159, 1015-1026 (2014
49. Siepel, A., & Haussler, D. Phylogenetic estimation of context-dependent substitution rates by maximum likelihood. Mol. Biol. Evol. 21, 468-488 (2004